Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study to Evaluate the Efficacy of the Investigational Products on Complete Spontaneous Bowel Movements in Participants Who Normally Have ≤ 3 Complete Spontaneous Bowel Movements Per Week But Are Otherwise Healthy

Low and High doses of Actazin and Livaux will be compared against a control formula and placebo to evaluate how each investigational study product effects complete spontaneous bowel movements in healthy adults that currently experience less than or equal to 3 complete spontaneous bowel movements per week. During the 28-day study period, it is hypothesized that participants consuming Acatzin, Livaux, or control formula will have an increased number of complete spontaneous bowel movements when compared to participants consuming the placebo. It is hypothesized that participants consuming Actazin or Livaux will respond more than participants consuming the control formula. It is hypothesized that participants consuming Actazin or Livaux will have a favorable microbiome change than placebo.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - Actazin (green kiwi powder) High Dose

Participants will consume 4 capsules (600 mg green kiwi powder) daily for 28-days

Dietary Supplement - Actazin (green kiwi powder) Low Dose

Participants will consume 4 capsules (150 mg green kiwi powder) daily for 28-days

Dietary Supplement - Control Formula (Actazin green kiwi powder + PreticX prebiotic)

Participants will consume 4 capsules (150 mg green kiwi powder + 250 mg PreticX prebiotic) daily for 28-days

Dietary Supplement - Livaux (gold kiwi powder) High Dose

Participants will consume 4 capsules (600 mg gold kiwi powder) daily for 28-days

Dietary Supplement - Livaux (gold kiwi powder) Low Dose

Participants will consume 4 capsules (150 mg gold kiwi powder) daily for 28-days

Dietary Supplement - Placebo (microcrystalline cellulose)

Participants will consume 4 capsules containing no active ingredients daily for 28-days

Additional Information

Official Study Title

A Single-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy of the Investigational Products on Complete Spontaneous Bowel Movements in Participants Who Normally Have ≤ 3 Complete Spontaneous Bowel Movements Per Week But Are Otherwise Healthy

Clinical Trial ID

NCT03462199

ParticipAid ID

9b6Dze